Disappointed Endologix stumbles as FDA calls for more Nellix EVAS system data Nov. 18, 2016 By Liz Hollis A "disappointed" Endologix Inc. (Nasdaq:ELGX) now is anticipating a second quarter 2018 approval of the Nellix endovascular aneurysm sealing (EVAS) system following the FDA's request for two-year patient follow-up data. Read More
Boston Scientific scoops up gynecology, urology portfolio from Distal Access Nov. 16, 2016 By Liz Hollis
Eyeing CMS bundling initiative, Medtronic inaugurates business for orthopedics solutions Nov. 11, 2016 By Liz Hollis
Righteye, researchers look to improve sports related concussion diagnosis with rapid tests Nov. 10, 2016 By Liz Hollis
FDA gives green light to Seaspine's Mariner fixation system ahead of its earnings report Nov. 9, 2016 By Liz Hollis
Second Sight looks to advance cortical prosthesis following successful implant Oct. 26, 2016 By Liz Hollis
